Golden State Wealth Management LLC Acquires Shares of 319 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Golden State Wealth Management LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 319 shares of the exchange traded fund’s stock, valued at approximately $29,000.

Several other institutional investors and hedge funds have also recently modified their holdings of XBI. Strategic Financial Concepts LLC bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $2,447,000. Telos Capital Management Inc. boosted its position in shares of SPDR S&P Biotech ETF by 6.6% in the fourth quarter. Telos Capital Management Inc. now owns 27,816 shares of the exchange traded fund’s stock valued at $2,505,000 after acquiring an additional 1,710 shares during the period. Econ Financial Services Corp bought a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $1,946,000. Money Concepts Capital Corp boosted its position in shares of SPDR S&P Biotech ETF by 6.0% in the fourth quarter. Money Concepts Capital Corp now owns 245,148 shares of the exchange traded fund’s stock valued at $22,078,000 after acquiring an additional 13,875 shares during the period. Finally, Lion Street Advisors LLC boosted its position in shares of SPDR S&P Biotech ETF by 11.4% in the fourth quarter. Lion Street Advisors LLC now owns 4,393 shares of the exchange traded fund’s stock valued at $396,000 after acquiring an additional 450 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $89.05 on Wednesday. The firm has a 50-day moving average of $92.23 and a 200-day moving average of $96.30. The stock has a market cap of $6.79 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.